Copy
Hello GIANT community member,

Welcome to GIANT Health's weekly newsletter.

What is the "Future of Clinical Trials" for evidence-based healthcare?
Who are the top 4 (5? 6? 7?) stakeholder groups you need to engage with?
Learn more about the decentralisation, and digital innovation of clinical trials at The GIANT Health Event 2021.

Would you like to network with 1000s and 1000s of Europe's leading healthcare and technology innovators, hospital leaders, health-sector investors, and entrepreneurs?  Over 400 speakers will convene in 15+ conference at the massive GIANT Health Event, 30 November - 1 December, 2021. 

Come join us in person or remotely.  Super Early Bird tickets are now available.
CLAIM YOUR TICKET HERE
 

Here at GIANT we just want to say thank you for being a part of our innovative health-tech community. If you found this email valuable, it is likely that others will too, so please Forward to a friend

Did a friend forward this to you? Sign up for our newsletter here: NEWSLETTER SIGN UP

Best wishes,

Barry Shrier, Founder, GIANT Health
@Barry_HealthTec
+44 7776 132 517

PS - Are you recruiting, looking for a hospital trial partner, in fundraising mode, looking for a job...please get in touch and we'll be happy to support you in this newsletter. 
 

Latest News in Healthtech Innovation

Salford Care introduces a new remote monitoring app for heart failure patients. The tech includes a smartphone app that is designed by Dignio and is currently being used by teams in Salford to remotely monitor heart failure patients who may have received reduced check-ups during the COVID-19 pandemic. The app is designed so that patients can be monitored from their home and self-manage some of their care, with an overall aim to reduce future hospital admissions.

More here

On June 22, 2021, conversationHEALTH released new updates and additions to their SaaS platform, their conversational AI platform. The new features include new machine learning based two-tier adverse event and product complaint handling, and just-in-time gating as well as customizable gating disclaimers. These features are added to the suite of customer configurations that help Life Sciences companies better adapt the platform to specific regional requirements or lines of business needs. 

Check out more here

Very cool!
Digital innovation - 3D printing of human body parts to improve performance, reduce infection
A new 3D printing method from researchers at the University of Nottingham can improve performance and bacterial resistance. The team has discovered how to tailor-make artificial body parts and other medical devices with built-in functionality that offers better shape and durability, all while removing the risk of bacterial infection at the same time. Most mass produced medical devices fail to completely meet the unique needs of users and single-material 3D printed methods have many design limitations. The team made for the first time a multi-material 3D-print technique, and they demonstrate that it is possible to combine complex functions within one customized healthcare device to enhance patient wellbeing.

More here

Health Innovator:  Professor Suneetha Ramani Moonesinghe

GIANT Health is proud to champion and advocate the passionate, selfless work of healthcare providers. Congratulations to University College London Hospitals NHS Foundation Trust (UCLH), Professor Suneetha Ramani Moonesinghe, Consultant Anaesthetist, receives an OBE for services to anaesthesia, perioperative and critical care.

More here

Fundraising - leading health tech innovators raising capital

The Boston, USA-based startup, NuvoAir, raises $12 million in a Series A funding led by London-based AlbionVC. NuvoAir uses an app to listen to your night-time coughing and other health data to inform people with ongoing respiratory illnesses and help them manage their health. 

Check out more here

"Reasons to be cheerful, Part 3:"

Thermo Fisher Scientific has launched a new CE-IVD-marked COVID-19 test that can expand the range of current and future mutations. The kit uses an assay design which then compensates for current and emerging variants by using eight total targets across three genomic regions of the virus. This then helps ensure that the test provides accurate results even as the virus continues to mutate. 

More here

Sales Associate job vacancy @ GIANT Health

Are you excessively passionate about building a successful sales career with massive prospects for promotion?  GIANT Health has a full-time remote role, with a reward structure centred around performance-based pay.

  • Sales commissions: OTE:  £48,000 (uncapped)

Apply here.

 

GIANT Health is the leading global Healthcare innovation community of nearly 200,000 people passionately committed to improving health outcomes by way of tech innovation.
We are mission-driven.

Get in touch to discuss partnership opportunities. 

Barry Shrier, Founder, GIANT Health
@Barry_HealthTec   |   +44 7776 132 517

PS: Are you recruiting, looking for a hospital trial partner, in fundraising mode, looking for a job...please get in touch and we'll be happy to support you in this newsletter. 
GIANT would like to thank our sponsors for their support, you guys are great!


Here at GIANT we just want to say thank you for being a part of our innovative health-tech community. If you found this email valuable, it is likely that others will too, so please Forward to a friend

Did a friend forward this to you? Sign up for our newsletter here: NEWSLETTER SIGN UP

We are writing to you because we consider you a valuable member of the global health tech community.







.






.






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
GIANT Health Event · 1-6 Speedy Place · Cromer Street · London, London WC1H 8BS · United Kingdom